Croda nudges ahead of expectations

Croda Speciality chemicals 2005

Speciality chemicals maker boosted by weak pound

Corporate Diary

Top chemical and pharma groups among companies reporting

Johnson Matthey’s mixed feelings on Brexit

Decline in sterling boosts revenues but workforce worried

Legal & General offices.

L&G bigs up ICI bulk annuity deal

Insurer’s shares have fallen a fifth since vote to leave EU

Monsanto rejects revised $64bn Bayer bid

US group says offer is too low and does not ensure deal certainty

Bayer lifts bid for Monsanto to $64bn

Deal would create world’s largest supplier of seeds

Picture shows David Isaac, CEO, Equality and Human Rights Commission. PHOTOGRAPH BY DANIEL JONES 2016 07815 853503
©Daniel Jones

UK equality watchdog vows ‘muscular’ approach

David Isaac to use ‘lightning strike’ inquiries and interventions

Monsanto in strategic talks beyond Bayer

US agribusiness eyes options after rejecting German group’s bid

BASF buys $3.2bn surface treatment unit

German chemicals group makes largest purchase since 2011


RPC to buy BPI in £261m packaging deal

Deal will increase group’s presence in plastic packaging products

Lotte Chemical makes Axiall counterbid

Offer comes after rejection of $3.1bn Westlake approach

Shell to build large-scale chemical plant

Plans unveiled as oil group targets more savings from BG takeover

Car emissions drive lifts Johnson Matthey

Strict requirements for diesel cars in EU boost autocatalyst maker

Bayer-Monsanto sows seeds of doubt

Antitrust officials likely to raise issues such as the impact on R&D

Agribusiness: Swarm of controversy

A Bayer-Monsanto merger is an environmentalist’s nightmare but how solid is the underlying science?

Bayer courts environmental bogeyman

Monsanto is despised by green movement for its status as the world’s largest maker of GM seeds

Monsanto opens door to talks on Bayer bid

US seeds group rejects $62bn offer but highlights benefits of a combination on the right terms

How predator Monsanto became the pursued

Does rejected Bayer have muscle to offer more acceptable price?

Crackdown on tax inversions sinks $8bn deal

CF Industries and OCI scrap planned tie-up after US rules change ‘materially reduced’ its value

Bayer bets big with $62bn Monsanto offer

Some investors fear German group will have to raise its bid


More FT Twitter accounts